April 14, 2022
Osivax Appoints Dr. Michael Watson, Former President of Moderna Vaccine Division, to Its Board of Directors
Osivax, a biopharmaceutical company developing vaccines to protect against highly mutating infectious diseases, has appointed Dr. Michael Watson to its Board of Directors.